228 related articles for article (PubMed ID: 31502764)
1. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience.
Lv W; Qu H; Wu M; Fan Z; Huang F; Xu N; Xuan L; Lin R; Zhao K; Sun J; Lai Y; Xu Y; Liu Q
Cancer Med; 2019 Nov; 8(15):6549-6558. PubMed ID: 31502764
[TBL] [Abstract][Full Text] [Related]
2. Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation.
Yang X; Yang S; Sun A; Qiu H; Tang X; Han Y; Wu D
Clin Transplant; 2018 Apr; 32(4):e13220. PubMed ID: 29493007
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA
Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital.
Wang M; Wang W; Abeywardane A; Adikarama M; McLornan D; Raj K; de Lavallade H; Devereux S; Mufti GJ; Pagliuca A; Potter VT; Mijovic A
Biol Blood Marrow Transplant; 2015 Jan; 21(1):60-6. PubMed ID: 25262883
[TBL] [Abstract][Full Text] [Related]
5. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
[TBL] [Abstract][Full Text] [Related]
6. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
Ahmed I; Teruya J; Murray-Krezan C; Krance R
Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
[TBL] [Abstract][Full Text] [Related]
7. Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.
Stocker N; Duléry R; Battipaglia G; Brissot E; Médiavilla C; Sestili S; Paviglianiti A; Ledraa T; Mohty R; Bazarbachi A; Belhocine R; Vekhoff A; Ruggeri A; Mohty M; Malard F
Eur J Haematol; 2019 Jul; 103(1):10-17. PubMed ID: 30958904
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of autoimmune hemolytic anemia after pediatric allogeneic stem cell transplant.
Hillier K; Harris EM; Berbert L; Pai SY; Grace RF
Pediatr Blood Cancer; 2022 Jan; 69(1):e29410. PubMed ID: 34709706
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study.
Li Y; Duan F; Xiao H; Wu X; Wang S; Xu D; Liu Q; Fan Z; Nie D; Lai Y; Wu B; Lin D; Du X; Weng J; Jiang Z; Pang Y; Ouyang L; Liu Z; Zhang L; Han N; Chen L; Xiao Y
Transplantation; 2018 Oct; 102(10):1724-1731. PubMed ID: 29677078
[TBL] [Abstract][Full Text] [Related]
10. Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children.
Chang TY; Jaing TH; Wen YC; Huang IA; Chen SH; Tsay PK
Medicine (Baltimore); 2016 Nov; 95(46):e5396. PubMed ID: 27861376
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features of Chronic Graft-Versus-Host Disease Following Haploidentical Transplantation Combined with Infusion of a Cord Blood.
Tao T; Li Z; Chu XL; Zhu WJ; Xu Y; Wu DP; Ma X; Xue SL
Stem Cells Dev; 2019 Jun; 28(11):745-753. PubMed ID: 30977441
[TBL] [Abstract][Full Text] [Related]
12. The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.
Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Clin Transplant; 2019 Jun; 33(6):e13537. PubMed ID: 30873642
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects.
Koo J; Giller RH; Quinones R; McKinney CM; Verneris MR; Knight-Perry J
Pediatr Blood Cancer; 2020 Sep; 67(9):e28591. PubMed ID: 32658382
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell Transplant compared with matched sibling and unrelated donor.
Lv W; Fan Z; Huang F; Xu N; Xuan L; GuopanYu ; Jiang Q; Zhou H; Lin R; Zhang X; Sun J; Liu Q
Oncotarget; 2017 Apr; 8(16):26505-26514. PubMed ID: 28460445
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience.
Sanz J; Arango M; Carpio N; Montesinos P; Moscardó F; Martín G; López F; Jarque I; Lorenzo I; de la Rubia J; Solves P; Boluda B; Salazar C; Cañigral C; Sanz MA; Sanz GF
Bone Marrow Transplant; 2014 Aug; 49(8):1084-8. PubMed ID: 24887383
[TBL] [Abstract][Full Text] [Related]
17. Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Yan CH; Xu LP; Liu DH; Chen H; Wang Y; Wang JZ; Wang FR; Han W; Liu KY; Huang XJ
Clin Transplant; 2015 Jul; 29(7):594-605. PubMed ID: 25969866
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes in allogeneic haematopoietic stem cell transplantation: A comparison between young and elderly patients. Observational study.
Chapchap EC; Kerbauy LN; Esteves I; Belucci TR; Rodrigues M; Kerbauy FR; de Souza Santos FP; Ribeiro AAF; Hamerschlak N
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13122. PubMed ID: 31257689
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.
Park JA; Lee HH; Kwon HS; Baik CR; Song SA; Lee JN
Transfus Med Rev; 2016 Jan; 30(1):6-14. PubMed ID: 26481836
[TBL] [Abstract][Full Text] [Related]
20. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]